EPS

The life sciences giant's significant dividend hike underscores its robust financial health and commitment to growth, even as it pursues major acquisitions.

All eyes are on Micron's March 18 report as a key test of the AI-fueled memory market recovery and the firm's strategic pivot to high-value tech.

Euroholdings declared a dividend on solid Q4 results, but a $10.2M one-time gain skews its full-year profits as it bets big on the tanker market.

The tech firm announced progress on a major health contract, but with its stock near all-time lows, can this deal deliver a much-needed turnaround?

After a massive divestiture, Brightstar Lottery slashes debt, rewards investors, and sets its sights on digital expansion in Italy and Brazil.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

With key conferences ahead, Supernus Pharmaceuticals must prove its strategy can deliver growth in the competitive central nervous system drug landscape.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

With promising data in cancer and eczema, all eyes are on Corvus Pharmaceuticals as it presents its lead drug at a major healthcare conference this week.

Following strong earnings and a major SAP settlement, Teradata will detail its AI-driven future and financial outlook at two key investor conferences.

As Flex heads to a key investor conference, a look at its record financials and pivotal role in building the high-stakes infrastructure for the AI era.

Steel giant Nucor announces a massive new share repurchase and its 212th straight dividend, signaling deep confidence in its future and the broader economy.

As MARA preps its Q4 earnings call, investors look beyond Bitcoin to see if its ambitious digital energy and AI infrastructure strategy is paying off.

The specialty insurer posted 30% premium growth and a record-low combined ratio, crediting its AI-driven underwriting platform for its success.

A new report reveals Americans face a $5 trillion annual bill burden, with essential costs consuming an alarming share of income and pushing families to the brink.

Climbing Entrepreneur's Franchise 500, this Verizon retailer reveals a model built on rapid growth, robust franchisee support, and deep community roots.

Pharma giant AbbVie raises its dividend, backed by robust financials and a powerful drug pipeline that signals a thriving post-Humira growth era.

The safety science giant posted record 2025 earnings and a strong 2026 outlook, sharpening its focus on high-growth tech with a key divestiture.

With two blockbuster cancer drugs driving record revenue, all eyes are on Syndax's upcoming earnings call for its 2026 outlook and growth strategy.

CenterPoint Energy reports strong 2025 earnings and accelerates its forecast for Houston's power needs, boosting its 10-year capital plan to $65.5 billion.